HOME
Lung Cancer Awareness Month
Month:
February 2018
What lies beneath grey matter atrophy in multiple sclerosis?
VIDEO: Brain Volume Loss and Disability Progression in MS
Ozanimod Demonstrates Efficacy and Safety in Phase 3 Trial of Relapsing Multiple Sclerosis
StatPearls Question of the Week – #1
MS could be reversed with existing allergy drug
MS: Blood test offers new way to monitor disease activity
Gray matter networks and cognitive impairment in multiple sclerosis
Dietary Fat, Relapse Linked in Pediatric Multiple Sclerosis
×